BrainStorm Cell Therapeutics Inc. issued the following announcement on Nov. 5.
BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that the Company will hold a conference call to update shareholders on financial results for the third quarter ended September 30, 2019, and provide a corporate update, at 8:00 a.m., Eastern Standard Time, on Thursday, November 14, 2019.
BrainStorm’s President & CEO, Chaim Lebovits, will present a corporate update, after which, participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be Ralph Kern, MD, MHSc, Chief Operating Officer and Chief Medical Officer, and Preetam Shah, PhD, Chief Financial Officer.
Participants are encouraged to submit their questions prior to the call by sending them to: email@example.com; Questions should be submitted by 5:00 p.m., Eastern Standard Time, Tuesday, November 12.
The investment community may participate in the conference call by dialing the following numbers:
|Toll Free:||Toll Free: 1-877-423-9813|
|Audio Webcast:||Link to Webcast|
A webcast replay of the conference call will be available for 30 days on the “Investors & Media” page of BrainStorm’s website:
|Replay Pin Number:||13696529|
|Replay Start:||Thursday, November 14, 2019, 11:00 AM ET|
|Replay Expiry:||Thursday, November 28, 2019, 11:59 PM ET|
Original source can be found here.